Earnings History Data for Arcturus Therapeutics Holdings Inc. (ARCT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as Alcobra Ltd, is based in San Diego, CA.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-11-2022 AH 4:00 PM ET
(Nov 9)
ARCT Arcturus Therapeutics Holdings Inc. 610.19 -1.33 -2.01 -2.05 Arcturus Therapeutics GAAP EPS of -$1.33 beats by $0.44, revenue of $13.4M beats by $9.31M
[11/9/2022 4:03 PM]
19.45 -1.64 
(-7.75%)
20.00 -1.09 
(-5.17%)
11.70 - 48.75 1,078,110 950,000 19,817
09-08-2022 AH 4:00 PM ET
(Aug 9)
ARCT Arcturus Therapeutics Holdings Inc. 446.74 -0.82 -1.84 -2.07 Arcturus Therapeutics GAAP EPS of -$0.82 beats by $1.04, revenue of $27.09M beats by $24.58M
[8/9/2022 4:04 PM]
17.48 -0.75 
(-4.11%)
17.65 -0.58 
(-3.18%)
11.70 - 65.00 512,975 410,000 4,131
09-05-2022 AH 4:00 PM ET
(May 9)
ARCT Arcturus Therapeutics Holdings Inc. 532.78 -1.94 -1.29 -2.15 Arcturus Therapeutics GAAP EPS of -$1.94 misses by $0.63, revenue of $5.24M misses by $1.84M
[5/9/2022 4:31 PM]
16.50 -0.11 
(-0.66%)
16.00 -0.61 
(-3.67%)
15.71 - 65.00 736,075 540,000 8,624
28-02-2022 AH 4:00 PM ET
(Feb 28)
ARCT Arcturus Therapeutics Holdings Inc. 611.56 -1.47 -1.77 -1.25 Arcturus Therapeutics GAAP EPS of -$1.47 beats by $0.16, revenue of $5.8M misses by $5.85M
[2/28/2022 4:03 PM]
22.05 -1.92 
(-8.03%)
22.60 -1.37 
(-5.72%)
19.68 - 65.00 554,732 410,000 1,431
08-11-2021 AH 4:00 PM ET
(Nov 8)
ARCT Arcturus Therapeutics Holdings Inc. 1,180 -2.05 -1.40 -0.92 Arcturus Therapeutics EPS misses by $0.72, misses on revenue
[11/8/2021 4:45 PM]
36.27 -2.38 
(-6.16%)
37.10 -1.55 
(-4.01%)
24.87 - 129.71 1,039,909 490,000 5,264
09-08-2021 AH 4:00 PM ET
(Aug 9)
ARCT Arcturus Therapeutics Holdings Inc. 824.09 -2.07 -1.99 -0.55 Arcturus Therapeutics EPS beats by $0.16, misses on revenue
[8/9/2021 4:05 PM]
50.57 2.33 
(4.83%)
58.61 10.37 
(21.50%)
24.87 - 129.71 6,029,418 2,090,000 363,069
10-05-2021 AH 4:00 PM ET
(May 10)
ARCT Arcturus Therapeutics Holdings Inc. 945.56 -2.15 -1.16 -0.67 Arcturus Therapeutics EPS misses by $0.87, misses on revenue
[5/10/2021 4:05 PM]
27.12 -1.78 
(-6.17%)
26.80 -2.11 
(-7.30%)
25.22 - 129.71 1,386,343 560,000 12,240
01-03-2021 AH 4:00 PM ET
(Mar 1)
ARCT Arcturus Therapeutics Holdings Inc. 1,640 -1.25 -0.90 -0.76 Arcturus Therapeutics EPS misses by $0.33, misses on revenue
[3/1/2021 4:04 PM]
53.96 -0.68 
(-1.24%)
53.50 -1.14 
(-2.09%)
8.51 - 129.71 599,043 1,071,529 777
09-11-2020 AH 4:00 PM ET
(Nov 9)
ARCT Arcturus Therapeutics Holdings Inc. 1,500 -0.92 -0.47 -0.56 Arcturus Therapeutics EPS misses by $0.44, misses on revenue
[11/9/2020 4:06 PM]
39.25 4.64 
(13.41%)
37.25 2.64 
(7.63%)
8.51 - 66.24 2,493,910 843,802 34,095
10-08-2020 AH 4:00 PM ET
(Aug 10)
ARCT Arcturus Therapeutics Holdings Inc. 1,370 -0.55 -0.53 -0.07 Arcturus Therapeutics EPS beats by $0.02, misses on revenue
[8/10/2020 4:10 PM]
51.58 -7.33 
(-12.44%)
58.77 -0.14 
(-0.24%)
8.51 - 63.45 715,512 903,969 3,494